Cargando…
Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations
Background and Aims: The increasing prevalence and absence of effective global treatment for metabolic syndrome (MetS) are alarming given the potential progression to severe non-communicable disorders such as type 2 diabetes and nonalcoholic fatty liver disease. The purpose of this study was to inve...
Autores principales: | Sauvé, Mathilde Foisy, Feldman, Francis, Koudoufio, Mireille, Ould-Chikh, Nour-El-Houda, Ahmarani, Lena, Sane, Alain, N’Timbane, Thierry, El-Jalbout, Ramy, Patey, Nathalie, Spahis, Schohraya, Stintzi, Alain, Delvin, Edgard, Levy, Emile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469639/ https://www.ncbi.nlm.nih.gov/pubmed/34572325 http://dx.doi.org/10.3390/biomedicines9091140 |
Ejemplares similares
-
Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders
por: Feldman, Francis, et al.
Publicado: (2022) -
Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells
por: Foisy-Sauvé, Mathilde, et al.
Publicado: (2020) -
High-fat diet reveals the impact of Sar1b defects on lipid and lipoprotein profile and cholesterol metabolism
por: Auclair, Nickolas, et al.
Publicado: (2023) -
Intestinal protection by proanthocyanidins involves anti-oxidative and anti-inflammatory actions in association with an improvement of insulin sensitivity, lipid and glucose homeostasis
por: Koudoufio, Mireille, et al.
Publicado: (2021) -
SAR1B GTPase is necessary to protect intestinal cells from disorders of lipid homeostasis, oxidative stress, and inflammation
por: Sané, Alain, et al.
Publicado: (2019)